Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo
Burr D B, Hooser M. Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 1995; 17 (4): 431-433
Low- energy femoral fractures associated with the long-term use of bisphospho- nates: A case series from a Swiss university hospital
Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low- energy femoral fractures associated with the long-term use of bisphospho- nates: a case series from a Swiss university hospital. Drug Saf 2009; 32 (9): 775-785
An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
Kwek E B, Goh S K, Koh J S, Png M A, Howe T S. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 2008; 39 (2): 224-231
Low- energy femoral shaft fractures associated with alendronate use
Neviaser A S, Lane J M, Lenart B A, Edobor-Osula F, Lorich D G. Low- energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22 (5): 346-350
Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: Clues to the mechanism of increased bone fragility
Somford M P, Draijer F W, Thomassen B J, Chavassieux P M, Boivin G, Papapoulos S E. Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility. J Bone Miner Res 2009; 24 (10): 1736-1740